Tumour Necrosis Factor Gene Polymorphism and Disease Prevalence

Scandinavian Journal of Immunology

Volumn 74, Issue 6, 2011, Pages 522-547

  Qidwai, T ^a   Khan, F ^a  

^a CSIR CENTRAL INSTITUTE OF MEDICINAL AND AROMATIC PLANTS   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; ETANERCEPT; FC RECEPTOR; INFLIXIMAB; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ASTHMA; AUTOIMMUNE DISEASE; BEHAVIOR DISORDER; BEHCET DISEASE; BILIARY CIRRHOSIS; BINDING SITE; CARDIOVASCULAR DISEASE; CROHN DISEASE; DIABETES MELLITUS; DISEASE PREDISPOSITION; ENTERITIS; GENOTYPE; GRAVES DISEASE; HEMODIALYSIS PATIENT; INFECTION; NEOPLASM; NEUROLOGIC DISEASE; PREVALENCE; PRIORITY JOURNAL; PSORIASIS; REVIEW; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN DISEASE; TRANSCRIPTION REGULATION;

ANIMALS; EVOLUTION, MOLECULAR; GENE EXPRESSION REGULATION; HUMANS; POLYMORPHISM, GENETIC; PREVALENCE; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 81255176365     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2011.02602.x     Document Type: Review

References (174)

1. Nedwin GE, Naylor SL, Sakaguchi AY et al. Human lymphotoxin and tumor necrosis factor genes: structure, homology and chromosomal localization. Nucleic Acids Res 1985;13:6361-73.
2. Tsai EY, Jain J, Pesavento PA, Rao A, Goldfeld AE. Tumor necrosis factor alpha gene regulation in activated T cells involves ATF-2/Jun and NFATp. Mol Cell Biol 1996;16:459-67.
3. Tsytsykova AV, Goldfeld AE. Inducer-specific enhanceosome formation controls tumor necrosis factor alpha gene expression in T lymphocytes. Mol Cell Biol 2002;22:2620-31.
4. van Heel DA, Udalova IA, De Silva AP et al. Inflammatory bowel disease is associated with a TNF polymorphism that affects an interaction between the OCT1 and NF-kB transcription factors. Hum Mol Genet 2002;11:1281-9.
5. Asghar T, Yoshida S, Kennedy S et al. The tumor necrosis factor-a promoter -1031C polymorphism is associated with decreased risk of endometriosis in a Japanese population. Hum Reprod 2004;19:2509-14.
6. Bayley JP, Ottenhoff TH, Verweij CL. Is there a future for TNF promoter polymorphisms? Genes Immun 2004;5:315-29.
7. Rasmussen SK, Urhammer SA, Jensen JN, Hansen T, Borch-Johnsen K, Pedersen O. The -238 and -308G/A polymorphisms of tumor necrosis factor alpha gene promoter are not associated with features of the insulin resistance syndrome or altered birth weight in Danish Caucasians. J Clin Endocrinol Metab 2000;85:1731-4.
8. Mizuki N, Ohno S, Sato T et al. Microsatellite polymorphism between the tumor necrosis factor and HLA-B genes in Behcet's disease. Hum Immunol 1995;43:129-35.
9. Nadel S, Newport MJ, Booy R, Levin M. Variation in the tumor necrosis factor-alpha gene promoter region may be associated with death from meningococcal disease. J Infect Dis 1996;174:878-80.
10. Cabrera M, Shw MA, Sharples C et al. Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis. J Exp Med 1995;182:1259-64.
11. Fong KY, Howe HS, Tin SK, Boey ML, Feng PH. Polymorphism of the regulatory region of tumor necrosis factor alpha gene in patient with systemic lupus erythematosus. Ann Acad Med Singapore 1996;25:90-3.
12. Verjans GM, Brinkman BM, Van Doornik CE, Kijlstra A, Verweij CL. Polymorphism of tumour necrosis factor-alpha (TNF-alpha) at position -308 in relation to ankylosing spondylitis. Clin Exp Immunol 1994;97:45-7.
13. Wilson AG, Clay FE, Crane AM, Cork MJ, Duff GW. Comparative genetic association of human leukocyte antigen class II and tumor necrosis factor alpha with dermatitis herpetic formis. J Invest Dermatol 1995;104:856-8.
14. Negoro K, Kinouchi Y, Hiwatashi N et al. Crohn's disease is associated with Novel polymorphisms in the 50-flanking region of the tumor necrosis factor gene. Gastroenterology 1999;117:1062-7.
15. Wilson AG, di Giovine FS, Blakemore AI, Duff GW. Single base polymorphism in the human tumor necrosis factor alpha (TNF-alpha) gene detectable by NcoI restriction of PCR product. Hum Mol Genet 1992;1:353.
16. Koch M, Rett K, Volk E et al. The tumor necrosis factor alpha 2238G-A and 2308G-A promoter polymorphisms are not associated with insulin sensitivity and insulin secretion in young healthy relatives of type II diabetic patients. Diabetologia 2000;43:181-4.
17. Orchard TR, Chua CN, Ahmad T, Cheng H, Welsh KI, Jewell DP. Uveitis and erythema nodosum in inflammatory bowel disease: clinical features and the role of HLA genes. Gastroenterology 2002;123:714-8.
18. Raviglione MC, Snider DE, Kochi A. Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic. JAMA 1995;273:220-6.
19. World Health Organization. Global Tuberculosis Control-Surveillance, Planning, Financing. URL: (Accessed on 15 November 2009), 2009.
20. Schurr E. Is susceptibility to tuberculosis acquired or inherited? J Intern Med 2007;261:106-11.
21. Comstock GW. Tuberculosis in twins a re-analysis of the Prophit survey. Am Rev Respir Dis 1978;117:621-4.
22. Fernando SL, Britton WJ. Genetic susceptibility to mycobacterial disease in humans. Immunol Cell Biol 2006;84:125-37.
23. Hoal EG. Human genetic susceptibility to tuberculosis and other mycobacterial diseases. IUBMB Life 2002;53:225-9.
24. Malik S, Schurr E. Genetic susceptibility to tuberculosis. Clin Chem Lab Med 2002;40:863-8.
25. Sharma S, Ghosh B, Sharma SK. Association of TNF polymorphisms with sarcoidosis, its prognosis and tumour necrosis factor (TNF)-alpha levels in Asian Indians. Clin Exp Immunol 2008;151:251-9.
26. Sharma S, Sharma A, Kumar S, Sharma SK, Ghosh B. Association of TNF haplotypes with asthma, serum IgE levels, and correlation with serum TNF alpha levels. Am J Respir Cell Mol Biol 2006;35:488-95.
27. Ates O, Musellim B, Ongen G, Topal Sarikaya A. Interleukin-10, and tumor necrosis factor-alpha gene polymorphisms in tuberculosis. J Clin Immunol 2008;28:232-6.
28. Oh JH, Yang CS, Noh YK et al. Polymorphisms of interleukin-10 and tumour necrosis factor-alpha genes are associated with newly diagnosed and recurrent pulmonary tuberculosis. Respirology 2007;12:594-8.
29. Oral HB, Budak F, Uzaslan EK et al. Interleukin-10 (IL-10) gene polymorphism as a potential host susceptibility factor in tuberculosis. Cytokine 2006;35:143-7.
30. Qu Y, Tang Y, Cao D et al. Genetic polymorphisms in alveolar macrophage response-related genes, and risk of silicosis and pulmonary tuberculosis in Chinese iron miners. Int J Hyg Environ Health 2007;210:679-89.
31. Scola L, Crivello A, Marino V et al. IL-10 and TNF-alpha polymorphisms in a sample of Sicilian patients affected by tuberculosis: implication for ageing and life span expectancy. Mech Ageing Dev 2003;124:569-72.
32. Selvaraj P, Sriram U, Mathan Kurian S, Reetha AM, Narayanan PR. Tumour necrosis factor alpha (-238 and -308) and beta gene polymorphisms in pulmonary tuberculosis: haplotype analysis with HLA-A, B and DR genes. Tuberculosis 2001;81:335-41.
33. Vejbaesya S, Mahaisavariya P, Luangtrakool P, Sermduangprateep C. NRAMP1 and TNF-alpha polymorphisms and susceptibility to tuberculosis in Thais. Respirology 2007;12:202-6.
34. Sharma S, Rathored J, Ghosh B, Sharma SK. Genetic polymorphisms in TNF genes and tuberculosis in North Indians. BMC Infect Dis 2010;10:165.
35. Goulart LR, Goulart IM. Leprosy pathogenetic background: a review and lessons from other mycobacterial diseases. Arch Dermatol Res 2009;301:123-37.
36. Santos AR, Suffys PN, Vanderborght PR et al. Role of tumor necrosis factor-alpha and interleukin-10 promoter gene polymorphisms in leprosy. J Infect Dis 2002;186:1687-91.
37. Shaw MA, Donaldson IJ, Collins A et al. Association and linkage of leprosy phenotypes with HLA class II and tumour necrosis factor genes. Genes Immun 2001;2:196-204.
38. Franceschi DS, Mazini PS, Rudnick CC et al. Influence of TNF and IL10 gene polymorphisms in the immunopathogenesis of leprosy in the south of Brazil. Int J Infect Dis 2009;13:493-8.
39. Vanderborght PR, Matos HJ, Salles AM et al. Single nucleotide polymorphisms (SNPs) at -238 and -308 positions in the TNFalpha promoter: clinical and bacteriological evaluation in leprosy. Int J Lepr Other Mycobact Dis 2004;72:143-8.
40. Kaijzel EL, van Krugten MV, Brinkman BMN et al. Functional analysis of a human tumour necrosis factor alpha (TNF-alpha) promoter polymorphism related to joint damage in rheumatoid arthritis. Mol Med 1998;4:724-33.
41. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 1997;24:1-8.
42. Fishman D, Faulds G, Jeffery R et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998;102:1369-76.
43. Keuter M, Dharmana E, Gasem MH et al. Patterns of proinflammatory cytokines and inhibitors during typhoid fever. J Infect Dis 1994;169:1306-11.
44. Dunstan SJ, Hue NT, Rockett KR et al. A TNF region haplotype offers protection from typhoid fever in Vietnamese patients. Hum Genet 2007;122:51-61.
45. Meissner A, Mikkelsen TS, Gu H et al. Genome scale DNA methylation maps of pluripotent and differentiated cells. Nature 2008;454:766-70.
46. Pociot F, Briant L, Jongeneel CV et al. Association of tumour necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-α and TNF-β by human mononuclear cells: a link to insulin dependent diabetes mellitus. Eur J Immunol 1993;23:224-31.
47. Wheeler AP, Bernard GR. Treating patients with severe sepsis. N Engl J Med 1999;340:207-14.
48. Mira JP, Cariou A, Grall F. Association of TNF2, a TNF-a promoter polymorphism, with septic shock susceptibility and mortality. JAMA 1999;282:561-8.
49. McGuire W, Knight JC, Hill AV, Allsopp CE, Greenwood BM, Kwiatkowski D. Severe malarial anemia and cerebral malaria are associated with different tumor necrosis factor promoter alleles. J Infect Dis 1999;179:287-90.
50. Forte GI, Scola L, Misiano G et al. Relevance of gamma interferon, tumor necrosis factor alpha, and interleukin-10 gene polymorphisms to susceptibility to Mediterranean spotted fever. Clin Vaccine Immunol 2009;16:811-5.
51. Kim YJ, Lee HS, Yoon JH et al. Association of TNF-promoter polymorphisms with the clearance of hepatitis B virus infection. Hum Mol Genet 2003;12:2541-6.
52. Somi MH, Najafi L, Noori NB et al. Tumor necrosis factor-alpha gene promoter polymorphism in Iranian patients with chronic hepatitis B. Indian J Gastroenterol 2006;25:14-5.
53. Wang S, Wei M, Han Y et al. Roles of TNF-α gene polymorphisms in the occurrence and progress of SARS-Cov infection: a case-control study. BMC Infect Dis 2008;8:27.
54. Mac Lean L, Chisi JE, Odiit M et al. Severity of Human African Trypanosomiasis in East Africa Is Associated with Geographic Location, Parasite Genotype, and Host Inflammatory Cytokine Response Profile. Infect Immun 2004;72:7040-4.
55. Guivier E, Galan M, Salvador AR et al. TNF-alpha expression and promoter sequences reflect the balance of tolerance/resistance to Puumala hantavirus infection in European bank vole populations. Infect Genet Evol 2010;10:1208-17.
56. Ubalee R, Suzuki F, Kikuchi M et al. Strong association of a tumor necrosis factor-α promoter allele with cerebral malaria in Myanmar. Tissue Antigens 2001;58:407-10.
57. Aidoo M, McElroy PD, Kolczak MS, Terlouw DJ, Kuile FO, Nahlen B. Tumor necrosis factor-alpha promoter variant 2 (TNF2) is associated with pre-term delivery, infant mortality, and malaria morbidity in western Kenya: Asembo Bay Cohort Project IX. Genet Epidemiol 2001;21:201-11.
58. Hananantachai H, Patarapotikul J, Ohashi J et al. Significant association between TNF-α (TNF) promoter allele (-1031C, -863C, and -857C) and cerebral malaria in Thailand. Tissue Antigens 2007;69:277-80.
59. Sinha S, Mishra SK, Sharma S et al. Polymorphisms of TNF-enhancer and gene for FcγRIIa correlate with the severity of falciparum malaria in the ethnically diverse Indian population. Malar J 2008;7:13.
60. Mergani A, Khamis AH, Haboor AB et al. Lack of association between -308 tumor necrosis factor polymorphism and susceptibility to cerebral malaria among Central Sudanese children. Int J Genet Mol Biol 2010;2:67-71.
61. Aguiar EC, Prestes AL. TNF gene polymorphisms are associated with reduced survival in severe Chagas' disease cardiomyopathy patients. Microbes Infect 2006;8:598-603.
62. Mellick GD. TNF polymorphism and cardiovascular disease: TNF gene polymorphism and quantitative traits related to cardiovascular disease: getting to the heart of the matter. Eur J Hum Genet 2007;15:609-11.
63. Sato H, Silveira L, Fingerlin T et al. TNF polymorphism and bronchoalveolar lavage cell TNF-α levels in chronic beryllium disease and beryllium sensitization. J Allergy Clin Immunol 2007;119:687-96.
64. Moffett SP, Zmuda JM, Oakley JI et al. Tumor necrosis factor-α polymorphism, bone strength phenotypes, and the risk of fracture in older women. J Clin Endocrinol Metab 2005;90:3491-7.
65. Azmy IA, Balasubramanian SP, Wilson AG et al. Role of tumour necrosis factor gene polymorphisms (-308 and -238) in breast cancer susceptibility and severity. Breast Cancer Res 2004;6:395-400.
66. Gaudet MM, Milne RL, Cox A et al. Five polymorphisms and breast cancer risk: results from the breast cancer association consortium. Cancer Epidemiol Biomarkers Prev 2009;18:1610-6.
67. Jung JH, Chae YS, Moon JH et al. TNF superfamily gene polymorphism as prognostic factor in early breast cancer. J Cancer Res Clin Oncol 2010;136:685-94.
68. Deshpande A, Nolan JP, White PS et al. TNF-alpha promoter polymorphisms and susceptibility to human papillomavirus 16-associated cervical cancer. J Infect Dis, 2005;191:969-76.
69. Danforth KN, Rodriguez C, Hayes RB et al. TNF polymorphisms and prostate cancer risk. Prostate 2008;68:400-7.
70. Seidemann K, Zimmermann M, Book M et al. Tumor necrosis factor and lymphotoxin alfa genetic polymorphisms and outcome in pediatric patients with non-Hodgkin's lymphoma: results from Berlin-Frankfurt-Munster Trial NHL-BFM 95. J Clin Oncol 2005;23:8414-21.
71. Duell EJ, Casella DP, Burk RD, Kelsey KT, Holly EA. Inflammation, genetic polymorphisms in proinflammatory genes TNF-A, RANTES, and CCR5, and risk of pancreatic adenocarcinoma. Cancer Epidemiol Biomarkers Prev 2006;15:726.
72. Shih CM, Lee YL, Chiou HL et al. Association of TNF-alpha polymorphism with susceptibility to and severity of non-small cell lung cancer. Lung Cancer 2006;52:15-20.
73. Başturk B, Yavaşçaoǧlu I, Vuruşkan H, Goral G, Oktay B, Oral HB. Cytokine gene polymorphisms as potential risk and protective factors in renal cell carcinoma. Cytokine 2005;30:41-5.
74. Onishi T, Ohishi Y, Goto H et al. Study on the relationship between tumour necrosis factor gene polymorphism and prognosis in the patients with renal cell carcinoma. Nihon Hinyokika Gakkai Zasshi 1998;89:413-20.
75. Akkiz H, Bayram S, Bekar A et al. G-308A TNF-alpha polymorphism is associated with an increased risk of hepatocellular carcinoma in the Turkish population: case-control study. Cancer Epidemiol 2009;33:261-4.
76. Ozhan G, Yanar HT, Ertekin C, Alpertunga B. Polymorphisms in tumour necrosis factor alpha (TNFα) gene in patients with acute pancreatitis. Mediators Inflamm 2010;6:1155.
77. Makrythanasis P, Tzetis M, Rapti A et al. Cystic fibrosis conductance regulator, tumor necrosis factor, interferon alpha-10, interferon alpha-17, and interferon gamma genotyping as potential risk markers in pulmonary sarcoidosis pathogenesis in Greek patients. Genet Test Mol Biomarkers 2010;14:577-84.
78. Akcali A, Pehlivan S, Pehlivan M, Sever T, Akgul P, Neyal M. TNF-alpha promoter polymorphisms in multiple sclerosis: no association with -308 and -238 alleles, but the -857 alleles in associated with the disease in Turkish patients. Int J Immunogenet 2010;37:91-5.
79. Moffatt MF, Cookson WO. Tumour necrosis factor haplotypes and asthma. Hum Mol Genet 1997;6:551-4.
80. Huizinga TW, Westendorp RG, Bollen EL et al. TNF-alpha promoter polymorphisms, production, and susceptibility to multiple sclerosis in different groups of patients. J Neuroimmunol 1997;72:149-53.
81. Lucotte G, Bathelier C, Mercier G. TNF-alpha polymorphisms in multiple sclerosis: no association with -238 and -308 promoter alleles, but the microsatellite allele a11 is associated with the disease in French patients. Mult Scler 2000;6:78-80.
82. Aguillón JC, Cruzat A, Aravena O, Salazar L, Llanos C, Cuchacovich M. Could single-nucleotide polymorphisms (SNPs) affecting the tumour necrosis factor promoter be considered as part of rheumatoid arthritis evolution? Immunobiology 2006;211:75-84.
83. Lee YH, Ji D, Song GG. Tumor necrosis factor-alpha promoter -308A/G polymorphism and rheumatoid arthritis susceptibility: a metaanalysis. J Rheumatol 2007;34:43-9.
84. Chung WT, Choe JY, Jang WC et al. Polymorphisms of tumor necrosis factor-alpha promoter region for susceptibility to HLA-B27-positive ankylosing spondylitis in Korean population. Rheumatol Int 2010;1-9.
85. Lee YH, Song GG. Lack of association of TNF-alpha promoter polymorphisms with ankylosing spondylitis: a meta-analysis. Rheumatology 2009;48:1359-62.
86. Gu LQ, Zhu W, Pan CM et al. Tumor necrosis factor alpha (TNF-α) polymorphisms in Chinese patients with Graves' disease. Clin Biochem 2010;43:223-7.
87. Rich SS, Concannon P, Erlich H et al. The Type 1 Diabetes Genetics Consortium. Ann NY Acad Sci 2006;1079:1-8.
88. Roach JC, Deutsch K, Li S et al. Swedish Childhood Diabetes Study Group; Diabetes Incidence in Sweden Study Group Genetic mapping at 3-kilobase resolution reveáis inositol 1, 4, 5-triphosphate receptor 3 as a risk factor for type 1 diabetes in Sweden. Am J Hum Genet 2006;79:614-27.
89. Smyth DJ, Cooper JD, Bailey R et al. A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) región. Nat Genet 2006;238:617-9.
90. Krikovszky D, Vásárhelyi B, Tóth-heyn P, Körner A, Tulassay T, Madácsy L. Association between G-308A polymorphism of the tumor necrosis factor-alpha gene and 24-hour ambulatory blood pressure values in type 1 diabetic adolescents. Clin Genet 2002;62:474-7.
91. Kumar R, Goswami R, Agarwal S, Israni N, Singh SK, Rani R. Association and interaction of the TNF-alpha gene with other pro- and anti-inflammatory cytokine genes and HLA genes in patients with type 1 diabetes from North India. Tissue Antigens 2007;69:557-67.
92. Das SN, Baniasadi V, Kapuria V. Association of -308TNF-alpha promoter polymorphism with type 1 diabetes in North Indians. Int J Immunogenet 2006;33:411-6.
93. Noble JA, Valdés AM, Lane JA, Green AE, Erlich HA. Linkage disequilibrium with predisposing DR3 haplotypes accounts for apparent effects of tumor necrosis factor and lymphotoxin-alpha polymorphisms on type 1 diabetes susceptibility. Hum Immunol 2006;67:999-1004.
94. Deng GY, Maclaren NK, Huang HS, Zhang LP, She JX. No primary association between the -308 polymorphism in the tumor necrosis factor alpha promoter región and insulin-dependent diabetes mellitus. Hum Immunol 1996;45:137-42.
95. Boraska V, Skrabić V, Culić CV, Becić K, Kapitanović S, Zemunik T. Association of TNF promoter polymorphisms with type 1 diabetes in the South Croatian population. Biol Res, 2008;41:157-63.
96. Shin HD, Yang SW, Kim DH, Park Y. Independent association of tumor necrosis factor polymorphism with type 1 diabetes susceptibility. Ann N Y Acad Sci 2008;1150:76-85.
97. Kubaszek A, Pihlajamaki J, Komarovaski V et al. Promoter polymorphisms of the TNF-α (G-308A) and IL-6 (C-174G) genes predict the conversion from impaired glucose tolerance to type 2 diabetes the Finnish Diabetes Prevention Study. Diabetes 2003;52:1872-6.
98. Buraczynska K, Koziol-Montewka M, Majdan M, Tokarz A, Ksiazek A. Genetic determination of TNF and myeloperoxidase production in dialyzed patients with diabetic nephropathy. Ren Fail 2004;26:633-9.
99. Hampe J, Shaw SH, Saiz R et al. Linkage of inflammatory bowel disease to human chromosome 6p. Am J Hum Genet 1999;65:1647-55.
100. Dechairo B, Dimon C, van Heel D et al. Replication and extension studies of inflammatory bowel disease susceptibility regions confirm linkage to chromosome 6p (IBD3). Eur J Hum Genet 2001;9:627-33.
101. Rioux JD, Silverberg MS, Daly MJ et al. Genome wide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. Am J Hum Genet 2000;66:1863-70.
102. Westendorp RG, Langermans JA, Huizinga TW et al. Genetic influence on cytokine production and fatal meningococcal disease. Lancet 1997;349:170-3.
103. Kawasaki A, Tsuchiya N, Hagiwara K, Takazoe M, Tokunaga K. Independent contributions of HLA-DRB1 and TNF-α promoter polymorphisms to the susceptibility of Crohn's disease. Genes Immun 2000;1:351-7.
104. Tomita K, Chiba T, Sugai T, Habano W. Association between tumor necrosis factor-alpha and Fc-gamma receptor polymorphisms with infliximab in Crohn's disease. Hepatogastroenterology 2010;57:535-9.
105. Chagani T, Paré PD, Zhu S et al. Prevalence of tumor necrosis factor-α and angiotensin converting enzyme polymorphisms in mild/moderate and fatal/near-fatal asthma. Am J Respir Crit Care Med 1999;160:278-82.
106. Li Kam, Wa TC, Mansur AH, Britton J et al. Association between α-308 tumour necrosis factor promoter polymorphism and bronchial hyperreactivity in asthma. Clin Exp Allergy 1999;29:1204-8.
107. Bilolikar H, Nam AR, Rosenthal M, Davies JC, Henderson DC, Balfour-Lynn IM. Tumour necrosis factor gene polymorphism and childhood wheezing. Eur Respir J 2005;26:637-46.
108. Gao JM, Lin YG, Qiu CC et al. The association between tumor necrosis factor α gene polymorphism and asthma. Chin Med Sci J 2003;18:248-53.
109. Sandford AJ, Chan HW, Wong GW, Lai CK, Chan-Yeung M. Candidate genetic polymorphisms for asthma in Chinese schoolchildren from Hong Kong. Int J Tuberc Lung Dis 2004;8:519-27.
110. Witte JS, Palmer LJ, OConnor RD, Hopkins PJ, Hall JM. Relationship between tumour necrosis factor polymorphism TNFα-308 and risk of asthma. Eur J Hum Genet 2002;10:82-5.
111. Winchester EC, Millwood IY, Rand L, Penny MA, Kessling AM. Association of the TNF-alpha-308 (G→A) polymorphism with self-reported history of childhood asthma. Hum Genet 2000;107:591-6.
112. Wang TN, Chen WY, Wang TH, Chen CJ, Huang LY, Ko YC. Gene-gene synergistic effect on atopic asthma: tumour necrosis factor-α-308 and lymphotoxin-α-NcoI in Taiwan's children. Clin Exp Allergy 2004;34:184-8.
113. Louis R, Leyder E, Malaise M, Bartsch P, Louis E. Lack of association between adult asthma and the tumour necrosis factor alpha-308 polymorphism gene. Eur Respir J 2000;16:604-8.
114. Beghe B, Padoan M, Moss CT et al. Lack of association of HLA class I genes and TNF alpha-308 polymorphism in toluene diisocyanate-induced asthma. Allergy 2004;59:61-4.
115. Bucková D, Hollá LI, Vasků A, Znojil V, Vácha J. Lack of association between atopic asthma and the tumor necrosis factor alpha-308 gene polymorphism in a Czech population. J Investig Allergol Clin Immunol 2002;12:192-7.
116. Di Somma C, Charron D, Deichmann K, Buono C, Ruffilli A. Atopic asthma and TNF-308 alleles: linkage disequilibrium and association analyses. Hum Immunol 2003;64:359-65.
117. Shin HD, Park BL, Kim LH et al. Association of tumor necrosis factor polymorphisms with asthma and serum total IgE. Hum Mol Genet 2004;13:397-403.
118. Gao J, Shan G, Sun B, Thompson PJ, Gao X. Association between polymorphism of tumour necrosis factor α-308 gene promoter and asthma: a meta-analysis. Thorax 2006;61:466-71.
119. Juran BD, Atkinson EJ, Larson JJ et al. Carriage of a tumor necrosis factor polymorphism amplifies the cytotoxic T-lymphocyte antigen 4 attributed risk of primary biliary cirrhosis: evidence for a gene-gene interaction. Hepatology 2010;52:223-9.
120. Ahmad T, Wallace GR, James T et al. Mapping the HLA association in Behcet's disease. A role for tumor necrosis factor polymorphisms?. Arthritis Rheum 2003;48:807-13.
121. Davis JA, Visscher MO, Wickett RR, Hoath SB. Influence of tumour necrosis factor-alpha polymorphism -308 and atopy on irritant contact dermatitis in healthcare workers. Contact Dermatitis 2010;63:320-32.
122. Li C, Wang G, Gao Y, Liu L, Gao T. TNF-alpha gene promoter -238G>A and -308G>A polymorphisms alter risk of psoriasis vulgaris: a meta-analysis. J Invest Dermatol 2007;127:1886-92.
123. Cohen JD, Bournerias I, Buffard V et al. Psoriasis induced by tumor necrosis factor-a antagonist therapy: a case series. J Rheumatol 2007;34:380-5.
124. Yilmaz R, Altun B, Ozer N, Hazirolan T, Turgan C. Impact of cytokine genotype on cardiovascular surrogate markers in hemodialysis patients. Ren Fail 2010;32:806-16.
125. Chen YC, Hu JF, Chen P et al. Association of TNF-α gene with spontaneous deep intracerebral hemorrhage in the Taiwan population: a case control study. BMC Neurol 2010;10:41.
126. Rost NS, Greenberg SM, Rosand J. The Genetic Architecture of Intracerebral Hemorrhage. Stroke 2008;39:2166-73.
127. Kim OJ, Lee JH, Choi JK et al. Association between Tumor Necrosis Factor-Alpha (-308G→A and -238G→A) Polymorphisms and Homocysteine Levels in Patients with Ischemic Strokes and Silent Brain Infarctions. Cerebrovasc Dis 2010;30:483-90.
128. Laws SM, Perneczky R, Wagenpfeil S et al. TNF polymorphisms in Alzheimer disease and functional implications on CSF beta-amyloid levels. Hum Mutat 2005;26:29-35.
129. Yang L, Lu R, Jiang L, Liu Z, Peng Y. Expression and genetic analysis of tumor necrosis factor-alpha (TNF-alpha) G-308A polymorphism in sporadic Alzheimer's disease in a Southern China population. Brain Res 2009;9:178-81.
130. DiDi Bona D, Candore G, Franceschi C et al. Systematic review by meta-analyses on the possible role of TNF-alpha polymorphisms in association with Alzheimer's disease. Brain Res Rev 2009;61:60-8.
131. Tedde A, Putignano AL, Nacmias B, Bagnoli S, Cellini E, Sorbi S. Lack of association between TNF-alpha polymorphisms and Alzheimer's disease in an Italian cohort. Neurosci Lett 2008;446:139-42.
132. Pickering M, Cumiskey D, O' Connor JJ. Actions of TNF-alpha on glutamatergic synaptic transmission in the central nervous system. Exp Physiol 2005;90:663-70.
133. Kaneko M, Stellwagen D, Malenka RC, Stryker MP. Tumor necrosis factor-alpha mediates one component of competitive, experience- dependent plasticity in developing cortex. Neuron 2008;58:673-80.
134. McAfoose J, Baune BT. Evidence for a cytokine model of cognitive function. Neurosci Biobehav Rev 2009;33:355-66.
135. Baune BT, Ponath G, Rothermund M, Riess O, Funke H, Berger K. Association between genetic variants of IL-beta, IL-6 and TNF-alpha cytokines and cognitive performance in the elderly general population of the MEMO-study. Psychoneuroendocrinology 2008;33:68-76.
136. Beste C, Heil M, Domschke K, Baune BT, Konrad C. Associations between the tumor necrosis factor alpha gene (-308G→A) and event-related potential indices of attention and mental rotation. Neuroscience 2010;170:742-8.
137. Lotrich FE, Ferrell RE, Rabinovitz M, Pollock BG. Labile anger during interferon alpha treatment is associated with a polymorphism in Tumor Necrosis Factor alpha. Clin Neuropharmacol 2010;33:191-7.
138. Leung L, Cahill MC. TNF-α and neuropathic pain. J Neuroinflammation 2010;7:27.
139. Achrol AS, Pawlikowska L, McCulloch CE et al. Tumor Necrosis Factor-α 238G>A Promoter Polymorphism Is Associated with Increased Risk of New Hemorrhage in the Natural Course of Patients with Brain Arteriovenous Malformations. Stroke 2006;37:231-4.
140. Kennedy SH. Is there a genetic basis to endometriosis? Semin Reprod Endocrinol 1997;15:309-17.
141. Liu D, Metter EJ, Ferrucci L et al. TNF promoter polymorphisms associated with muscle phenotypes in humans. J Appl Physiol 2008;105:859-67.
142. Corral-Gudino L, del Pino-Montes J, García-Aparicio J, Alonso-Garrido M, González-Sarmiento R. Paget's disease of bone is not associated with common polymorphisms in interleukin-6, interleukin-8, and tumor necrosis factor alpha genes. Cytokine 2010;52:146-50.
143. Rojas J, Fernandez I, Pastor JC et al. A strong genetic association between the tumor necrosis factor locus and proliferative vitreoretinopathy: the retina 4 project. Ophthalmology 2010;117:2417-23.
144. Kimkong I, Hirankarn N, Nakkuntod J, Kitkumthorn N. Tumour necrosis factor-alpha gene polymorphisms and susceptibility to oral lichen planus. Oral Dis 2011;17:206-9.
145. Zammiti W, Mtiraoui N, Khairi H, Gris JC, Almawi WY, Mahjoub T. Associations between tumor necrosis factor-α and lymphotoxin-α polymorphisms and idiopathic recurrent miscarriage. Reproduction 2008;135:397-403.
146. Palmirotta R, La Farina F, Ferroni P et al. TNFA gene promoter polymorphisms and susceptibility to recurrent pregnancy loss in italian women. Reprod Sci 2010;17:659-66.
147. Jones PA, Baylin SB. The Fundamental Role of Epigenetic Events in Cancer. Nat Genet 2002;3:415-28.
148. Strunnikova M, Schagdarsurengin U, Kehlen A, Garbe JC, Stampfer MR, Dammann R. Chromatin inactivation precedes de novo DNA methylation during the progressive epigenetic silencing of the RASSF1A promoter. Mol Cell Biol 2005;25:3923-33.
149. Bird AP, Wolffe AP. Methylation-induced repression-belts, braces, and chromatin. Cell 1999;99:451-4.
150. Zhang Y, Rohde C, Tierling S et al. DNA methylation analysis of chromosome 21 gene promoters at single base pair and single allele resolution. PLoS Genet 2009;5: e1000438.
151. Weber M, Hellmann I, Stadler MB et al. Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome. Nat Genet 2007;39:457-66.
152. Eckhardt F, Lewin J, Cortese R et al. DNA methylation profiling of human chromosomes 6, 20 and 22. Nat Genet 2006;38:1378-85.
153. Milani L, Lundmark A, Kiialainen A et al. DNA Methylation for subtype classification and prediction of treatment outcome in patients with childhood acute lymphoblastic leukemia. Bood 2010;115:1214-25.
154. Andersen MC, Engström PG, Lithwick S et al. In silico detection of sequence variations modifying transcriptional regulation. PLoS Comput Biol 2008;4:e5.
155. Kuriki C, Tanaka T, Fukui Y, Sato O, Motojima K. Structural and functional analysis of a new upstream promoter of the human FAT/CD36 gene. Biol Pharm Bull 2002;25:1476-8.
156. Zabetian CP, Anderson GM, Buxbaum SG et al. A quantitative-trait analysis of human plasma-dopamine beta-hydroxylase activity: evidence for a major functional polymorphism at the DBH locus. Am J Hum Genet 2001;68:515-22.
157. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990;86:1343-6.
158. Skoog T, Vant Hoft FM, Kallin B et al. A Common functional polymorphism (C→A substitution at position -863) in the promoter region of tumour necrosis factor-α (TNF-α) gene associated with reduced circulating levels of TNF-α. Hum Mol Genet 1999;8:1443-9.
159. Kuo NW, Lympany PA, Menezo V et al. TNF-α 857T, a genetic risk marker for acute anterior uveitis. Invest Ophthalmol Vis Sci 2005;46:1565-71.
160. Wittkopp PJ. Variable Transcription Factor Binding: a Mechanism of Evolutionary Change. PLoS Biol 2010;8:e1000342.
161. Bradley RK, Li X-Y, Trapnell C, Wayne ML, Nuzhdin SV. Binding site turnover produces pervasive quantitative changes in transcription factor binding between closely related Drosophila species. PLoS Biol 2010;8:e1000343.
162. Wood N, Bhattacharya T, Keele BF et al. HIV evolution in early infection: selection pressures, patterns of insertion and deletion, and the impact of APOBEC. PLoS Pathog 2009;5:1000414.
163. Wilson MD, Barbosa-Morais NL, Schmidt D et al. Species-specific transcription in mice carrying human chromosome 21. Science 2008;322:434-8.
164. Graze RM, McIntyre LM, Main BJ, Wayne ML, Nuzhdin SV. Regulatory divergence in Drosophila melanogaster and D. simulans a genome-wide analysis of allele-specific expression. Genetics 2009;183:547-61.
165. Tirosh I, Reikhav S, Levy AA, Barkai N. A yeast hybrid provides insight into the evolution of gene expression regulation. Science 2009;324:659-62.
166. Yang Y, Luo C, Feng R, Bi S. The TNF-α, IL-1B and IL-10 polymorphisms and risk for hepatocellular carcinoma: a meta-analysis. J Cancer Res Clin Oncol 2010;137:947-52.
167. McCormick DP, Grady JJ, Diego A, et al. Acute otitis media severity: Association with cytokine gene polymorphisms and other risk factors. Int J Pediatr Otorhinolaryngol 2011;75:708-12.
168. Emonts M, Veenhoven RH, Wiertsema SP, et al. Genetic polymorphisms in immunoresponse genes TNFA, IL6, IL10, and TLR4 are associated with recurrent acute otitis media. Pediatrics 2007;120:814-23.
169. Majetschak M, Floh AS, Obertacke U, et al. Relation of a TNF gene polymorphism to severe sepsis in trauma patients. Ann Surg 1999;230:207-14.
170. Vejbaesya S, Chierakul N, Luangtrakool P, Sermduangprateep C. NRAMP1 and TNF-alpha polymorphisms and susceptibility to tuberculosis in Thais. Respirology 2007;12:202-6.
171. Drigo SA, Neto EC, Ianni B, et al. Goldberg AC Lack of association of tumour necrosis factor-α polymorphisms with Chagas disease in Brazilian patients. Immuno Lett 2007;108:109-11.
172. Cordeiro CA, Moreira PR, Andrade MS, et al. Interleukin-10 gene polymorphism (-1082G/A) is associated with toxoplasmic retinochoroiditis. Invest Ophthalmol Vis Sci 2008;49:1979-82.
173. Kimkong I, Hirankarn N, Nakkuntod J, Kitkumthorn N. Tumour necrosis factor-alpha gene polymorphisms and susceptibility to oral lichen planus. Oral Dis 2011;17:206-9.
174. Ahamad A, Stevens CW, Smythe WR, et al. Promising early local control of malignant pleural mesothelioma following postoperative intensity modulated radiotherapy (IMRT) to the chest. Cancer J 2003;9:476-84.